Frontiers in Allergy (Jun 2021)

Component-Resolved Diagnosis of American Cockroach (Periplaneta americana) Allergy in Patients From Different Geographical Areas

  • Andrea Wangorsch,
  • Annette Jamin,
  • Stephanie Eichhorn,
  • Isabel Pablos,
  • Swati Sharma,
  • Bettina Schweidler,
  • Bianca Kastner,
  • Sabrina Wildner,
  • Joachim Saloga,
  • Frank Führer,
  • Reinaldo Rafael Reyna Orozco,
  • Roya Sherkat,
  • Somayeh Sadeghi,
  • Fardis Teifoori,
  • Jung-Won Park,
  • Peter Briza,
  • Stefan Vieths,
  • Fatima Ferreira,
  • Naveen Arora,
  • Jonas Lidholm,
  • Gabriele Gadermaier,
  • Stephan Scheurer

DOI
https://doi.org/10.3389/falgy.2021.691627
Journal volume & issue
Vol. 2

Abstract

Read online

Background: Manifestation of respiratory allergy to American cockroach (Periplaneta americana) is prominent in the subtropical and tropical areas. However, co-existing perennial indoor inhalant allergies frequently compromise clinical diagnosis of cockroach allergy, and the analysis of sensitization pattern is limited by the lack of Periplaneta allergens widely available for component-resolved diagnostics (CRD).Objective: To evaluate a collection of previously described recombinant Periplaneta allergens for CRD in cockroach allergy.Methods: A panel of nine recombinant Periplaneta allergens (Per a 1–5, 7–10) was generated, purified, and subjected to physicochemical characterization by applying circular dichroism (CD) spectroscopy, dynamic light scattering (DLS), amino acid (AA) analysis, and mass spectrometry (MS). Patients (n = 117) from India, Korea, Venezuela, and Iran, reporting perennial respiratory indoor allergies with IgE sensitization to cockroach (P. americana and/or Blattella germanica), were included. The sensitization profile was monitored by the experimental ImmunoCAP testing.Results: ImmunoCAP testing confirmed IgE sensitization to Periplaneta and/or Blattella extract in 98 of 117 patients (r = 0.95). Five out of 117 patients were sensitized to only one of the two cockroach species. Within the whole study group, the prevalence of sensitization to individual allergens varied from 4% (Per a 2) to 50% (Per a 9), with the highest IgE values to Per a 9. Patients from four countries displayed different sensitization profiles at which Per a 3 and Per a 9 were identified as major allergens in India and Korea. Periplaneta-derived lipocalin and myosin light chain were characterized as new minor allergens, designated as Per a 4 and Per a 8. Periplaneta extract showed higher diagnostic sensitivity than all individual components combined, suggesting the existence of allergens yet to be discovered.Conclusion: Utilization of a panel of purified Periplaneta allergens revealed highly heterogeneous sensitization patterns and allowed the classification of lipocalin and myosin light chain from Periplaneta as new minor allergens.

Keywords